Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-771
Closed -$229K 162
2025
Q3
$229K Sell
771
-148
-16% -$42.9K 0.01% 126
2025
Q2
$257K Buy
919
+217
+31% +$61.5K 0.01% 117
2025
Q1
$219K Sell
702
-143
-17% -$42.2K 0.01% 110
2024
Q4
$220K Sell
845
-82
-9% -$24.3K 0.01% 105
2024
Q3
$299K Buy
+927
New +$303K 0.01% 81
2023
Q4
Sell
-2,307
Closed -$620K 104
2023
Q3
$620K Sell
2,307
-266
-10% -$66.4K 0.03% 41
2023
Q2
$571K Buy
2,573
+146
+6% +$33.9K 0.03% 44
2023
Q1
$610K Buy
2,427
+82
+3% +$20.1K 0.03% 49
2022
Q4
$616K Sell
2,345
-524
-18% -$140K 0.03% 46
2022
Q3
$647K Sell
2,869
-341
-11% -$82.7K 0.03% 54
2022
Q2
$781K Buy
3,210
+1,487
+86% +$364K 0.03% 61
2022
Q1
$417K Buy
1,723
+75
+5% +$17.2K 0.02% 197
2021
Q4
$371K Sell
1,648
-167
-9% -$35.2K 0.01% 243
2021
Q3
$386K Sell
1,815
-84
-4% -$19.3K 0.01% 242
2021
Q2
$463K Buy
+1,899
New +$467K 0.01% 264
2021
Q1
Sell
-493
Closed -$113K 294
2020
Q4
$113K Buy
+493
New +$114K ﹤0.01% 272

Other funds holding AMGN

Krane Funds Advisors's AMGN Position: Q4 2025 in Review

Krane Funds Advisors sold out of Amgen (AMGN) in Q4 2025, closing a stake of 771 shares — an estimated $229K sold.

Krane Funds Advisors first reported a position in AMGN in Q4 2020 and held it in 16 quarters. The position peaked at $781K in Q2 2022. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Krane Funds Advisors reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Krane Funds Advisors sold 771 Amgen shares in Q4 2025, an estimated $229K.
  • Krane Funds Advisors first reported a position in Amgen in Q4 2020 and held it in 16 quarters.
  • Krane Funds Advisors's Amgen position peaked at $781K in Q2 2022.
  • 3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Krane Funds Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.